2012
DOI: 10.1097/01258363-201209000-00063
|View full text |Cite
|
Sign up to set email alerts
|

The incidence of scalp skin metastases among patients used of the scalp cooling to prevent chemotherapy-induced alopecia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…In a retrospective cohort study, the metastasis incident is found to be 1.2% for women (6 incident in 553 patients) who had scalp cooling method and 1.1% for women (1 incident in 87 patients) who didn't have cold application treatment (41). In a meta-analysis, scalp metastasis incident is found 0.56% (12 in 2129 patients) (42). In addition all these, scalp cooling method is contraindicated in cases of, hematological malignancies (leukemia, multiple myeloma, non-Hodgkins and other generalized lymphomas), cold sensitivity, cold agglutinin disease, cryoglobulinemia, cryofibrinogenemia, cold traumatic dystrophy, melanoma patients with adjuvant or curative chemotherapy (43).…”
Section: Physical Methodsmentioning
confidence: 99%
“…In a retrospective cohort study, the metastasis incident is found to be 1.2% for women (6 incident in 553 patients) who had scalp cooling method and 1.1% for women (1 incident in 87 patients) who didn't have cold application treatment (41). In a meta-analysis, scalp metastasis incident is found 0.56% (12 in 2129 patients) (42). In addition all these, scalp cooling method is contraindicated in cases of, hematological malignancies (leukemia, multiple myeloma, non-Hodgkins and other generalized lymphomas), cold sensitivity, cold agglutinin disease, cryoglobulinemia, cryofibrinogenemia, cold traumatic dystrophy, melanoma patients with adjuvant or curative chemotherapy (43).…”
Section: Physical Methodsmentioning
confidence: 99%